CLC bio, imaGenes announce collaboration in high-throughput sequencing analyses

Today, the leading provider of High-Throughput Sequencing analysis solutions, CLC bio, announced that they're collaborating with premier German sequencing service provider, imaGenes, to better support the fast growing German market of high-throughput sequencing analyses. imaGenes, will provide all customers receiving Next Generation Sequencing data with a temporary license for CLC Genomics Workbench for assembly and downstream sequence analyses.

Director Bioinformatics & Services at imaGenes, Dr. Steffen Hennig, states, "We have been looking for a software platform which we could use to present our research results to our customers in an easy, coherent, and user-friendly way. Furthermore, we wanted the solution to be platform independent in the sense that our customers are running all the different Next Generation Sequencing instruments that are out there. When taking those requirements into consideration and looking into the high-throughput sequencing space, CLC bio is really the only viable solution, so in the end it was a straightforward decision on our part."

Director of EMEA Sales at CLC bio, Michel Seidelin, PhD, continues, "We have been looking for a sequencing service center partner in Germany for some time and after having engaged with several candidates, imaGenes stood out as being the premier service center of them all. imaGenes have impressed us here at CLC bio with the broad spectrum of analyses services they already provide to the scientific community, as well as the impressive quality reputation they have among our existing customers."

The collaboration means that imaGenes will provide their customers with research results in CLC bio's format, enabling them to easily view and post-process the data further, using CLC bio's software platform.